HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subramanian Hariharan Selected Research

Subramanian Hariharan Research Topics

Disease

19Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 01/2009
14Neoplasms (Cancer)
01/2022 - 08/2002
4Disease Progression
01/2019 - 08/2002
3Merkel Cell Carcinoma
01/2020 - 01/2017
2Hypertension (High Blood Pressure)
05/2013 - 05/2011
2Fatigue
05/2013 - 03/2012
1Dyslipidemias (Dyslipidemia)
10/2022
1Infections
01/2022
1COVID-19
01/2022
1Body Weight (Weight, Body)
01/2019
1Adrenocortical Carcinoma
10/2018
1Carcinoma (Carcinomatosis)
01/2018
1Myocarditis (Carditis)
01/2018
1Non-Muscle Invasive Bladder Neoplasms
01/2018
1Myocardial Infarction
12/2015
1Edema (Dropsy)
12/2015
1Proteinuria
12/2015
1Hypercholesterolemia
03/2014
1Neutropenia
03/2014
1Pneumonia (Pneumonitis)
03/2014
1Hyperglycemia
03/2014
1Hypophosphatemia
03/2014
1Stomatitis
03/2014
1Inflammation (Inflammations)
03/2014
1Hand-Foot Syndrome
05/2013
1Clear-cell metastatic renal cell carcinoma
05/2013
1Brain Neoplasms (Brain Tumor)
02/2011
1Cardiotoxicity
04/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2006
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2006
1Meningioma (Meningiomas)
08/2002
1Glioblastoma (Glioblastoma Multiforme)
05/2002

Drug/Important Bio-Agent (IBA)

15Sunitinib (Sutent)FDA Link
10/2022 - 04/2008
6Axitinib (AG 013736)IBA
10/2022 - 05/2013
6avelumabIBA
10/2022 - 01/2017
5B7-H1 AntigenIBA
01/2020 - 01/2017
4Immune Checkpoint InhibitorsIBA
10/2022 - 01/2017
4Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2011
3Sorafenib (BAY 43-9006)FDA Link
10/2014 - 09/2011
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2022 - 10/2014
2Monoclonal AntibodiesIBA
01/2020 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 05/2006
2AntibodiesIBA
01/2018 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 05/2011
2temsirolimusFDA Link
10/2014 - 03/2014
2Tyrosine Kinase InhibitorsIBA
10/2014 - 01/2009
2Interferon-alpha (Interferon Alfa)IBA
03/2014 - 01/2009
2Bevacizumab (Avastin)FDA Link
03/2014 - 09/2011
2InterferonsIBA
09/2011 - 01/2009
2Irinotecan (Camptosar)FDA LinkGeneric
10/2006 - 05/2006
1omega-Chloroacetophenone (Mace)IBA
10/2022
1Messenger RNA (mRNA)IBA
01/2022
1VaccinesIBA
01/2022
1BNT162 VaccineIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1LigandsIBA
11/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1PlatinumIBA
01/2018
1pembrolizumabIBA
01/2017
1CreatinineIBA
12/2015
1AmylasesFDA Link
12/2015
1TOR Serine-Threonine KinasesIBA
10/2014
1GemcitabineFDA Link
10/2006
1Docetaxel (Taxotere)FDA Link
10/2006
1Celecoxib (Celebrex)FDA Link
10/2006
1Etoposide (VP 16)FDA LinkGeneric
05/2006
1Hydroxyurea (Hydrea)FDA LinkGeneric
08/2002

Therapy/Procedure

11Therapeutics
10/2022 - 08/2002
3Drug Therapy (Chemotherapy)
01/2018 - 08/2002
1Immunotherapy
01/2018
1Nephrectomy
03/2014
1Aftercare (After-Treatment)
03/2012
1Duration of Therapy
08/2002
1Radiotherapy
08/2002
1Craniotomy
05/2002